Breast Cancer Research

official impact factor 5.79
Search for
Advanced search
Breast Cancer Research
Tools
Correction

Correction: Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1

Hans Neubauer1, Susan E Clare1,2, Wojciech Wozny3, Gerhard P Schwall3, Slobodan Poznanovic3, Werner Stegmann3, Ulrich Vogel4, Karl Sotlar4,5, Diethelm Wallwiener1, Raffael Kurek1,6, Tanja Fehm1 and Michael A Cahill3,7*

Author Affiliations

1 Department of Obstetrics and Gynecology, University of Tuebingen, Calwerstraße, 72076 Tübingen, Germany

2 Current Address: Department of Surgery, Indiana University School of Medicine, W Walnut Street, Indianapolis, Indiana, 46202, USA

3 ProteoSys AG, Carl-Zeiss-Straße, 55129 Mainz, Germany

4 Department of Pathology, University of Tuebingen, Liebermeisterstraße, 72076 Tübingen, Germany

5 Current Address: Department of Pathology, Ludwig-Maximilians-University of Munich, Thalkirchnerstraße, 80337 Munich, Gemany

6 Current Address: Merck-Serono – Global Clinical Development Unit Oncology, Merck KGaA, Frankfurter Straße, 64293 Darmstadt, Germany

7 School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2678, Australia

For all author emails, please log on.

Breast Cancer Research 2009, 11:401 doi:10.1186/bcr2216

Published: 13 January 2009

First paragraph (this article has no abstract)

Following the publication of our article [1] we noticed an error in the abstract, within the paragraph headed 'Results'. The serine residue, serine-181, referred to in this paragraph should be serine-180.